OneMedNet Network Exceeds 90M Patient Journeys and 270M Studies with 2,300 Sites
ONMD•OneMedNet’s iRWD network now exceeds 90 million patient journeys and 270 million studies, achieved through a 12.5% increase in patient journeys over two months. The network spans more than 2,300 healthcare partner sites following a 30% annual expansion and includes rare disease, oncology, cardiology and multimodal data coverage.
1. Network Growth Highlights
OneMedNet’s iRWD network surpassed 90 million patient journeys and 270 million studies, reflecting a 12.5% patient journey increase since April and a 30% year‐over‐year expansion in partner sites to over 2,300 locations.
2. Strategic Priorities Execution
This milestone fulfills the company’s core pillar of strategic network growth established at the end of 2025, demonstrating disciplined execution to meet accelerating demand for regulatory decision‐grade AI‐driven real‐world data.
3. Expanded Data Diversity
The network now offers comprehensive hard‐to‐find datasets across rare diseases, oncology, cardiology and more, enriched with multimodal diagnostic data including radiology, cardiology studies, EEG and ECG alongside de‐identified electronic health records.
4. Market Positioning and Outlook
With expanded provider partnerships and deep longitudinal data connections, OneMedNet is positioned to support life sciences organizations, drug developers and AI innovators seeking diverse, high‐quality real‐world data for future research and development.
